简体中文 | 繁體中文 | English

Products & Services News

2021-04-27 15:07 Technology Innovation Institute Joins the Quantum Computing Challenge with Launch of Open-Source ‘Qibo’
2021-04-27 14:36 SpeeDx Receives CE-IVD Mark for PlexPCR® SARS-CoV-2
2021-04-27 10:09 Private Salon “Club mesm” Launches on April 27, 2021 in Celebration of the 1st Anniversary of the Opening of mesm Tokyo, Autograph Collection
2021-04-27 09:12 Milliken & Company Publishes Third Annual Corporate Sustainability Report
2021-04-27 09:10 Coty Unveils Growth Acceleration Strategy at Investor Update Event
2021-04-26 17:44 Amazon Invests in Nine New Renewable Energy Projects in Canada, the U.S., Spain, Sweden, and the UK and Becomes Europe’s Largest Corporate Buyer of Renewable Energy
2021-04-26 16:16 HKTB Chairman Welcomes Agreement to Relaunch Bilateral Hong Kong-Singapore Air Travel Bubble
2021-04-26 15:19 MSCI Calls on Capital to Lead the Net-Zero Revolution
2021-04-26 13:11 XPRIZE and Musk Foundation Announce Guidelines and Open Registration for $100M XPRIZE Carbon Removal
2021-04-26 09:19 Merck Announces New Data Strengthening Evidence for Continued Safe and Effective MAVENCLAD® Use During the COVID-19 Pandemic
2021-04-26 09:08 LEO Pharma Receives Positive CHMP Opinion of Adtralza® (tralokinumab) for the Treatment of Adults With Moderate-to-Severe Atopic Dermatitis
2021-04-23 19:07 MSCI Announces Strategic Alliance With Royalty Pharma to Launch Life Sciences Indexes
2021-04-23 18:39 Algorand Pledges to be the Greenest Blockchain with a Carbon-Negative Network Now and in the Future
2021-04-23 16:45 Toyoda Gosei Enhances Production Capacity in China for Car Safety-Related Products
2021-04-23 16:19 OMNI CT Brings First-of-Its-Kind Waste to Hydrogen Product to Market in the Fight Against Climate Change
2021-04-23 13:31 Evoqua Water Technologies Releases 2020 Sustainability Report
2021-04-23 12:38 Utopia AI Determines Amounts of Hate Speech on Different Social Platforms
2021-04-23 12:33 SHINE, Phoenix merger focused on advancing fusion technology
2021-04-23 10:14 Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
2021-04-23 10:00 OAG Metis to Power Flight Information Innovation